Core Scientific, Inc./tx CORZ
Nasdaq · stock · Finance Services · website · IPO 2021-04-05
Core Scientific, Inc./tx statistics & valuation
Market cap$8.6B
P / S27.1×
Net margin-90.5%
FCF margin-141.3%
Net debt$748.9M
Enterprise value USD$9.4B
Earnings yield EBIT/EV-2.6%
Return on capital-15.7%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Gross margin | 11.9% | 23.7% | 24.6% | 1.3% | 43.9% | 15.6% |
| Operating margin | -77.0% | -27.8% | 1.8% | -329.5% | 24.2% | -10.5% |
| Net margin | -90.5% | -281.6% | -49.1% | -335.2% | 8.7% | -20.2% |
| FCF margin | -141.3% | -10.2% | 9.7% | -27.9% | -10.4% | -39.4% |
| Return on assets | -12.3% | -97.4% | -34.6% | -265.7% | 1.9% | -81373.3% |
| Return on equity | 30.0% | 152.5% | 41.3% | 524.3% | 3.5% | -13.7% |
| Debt / equity | -1.10× | — | — | — | — | — |
| Current ratio | 1.15 | 6.72 | 0.20 | 0.46 | 2.36 | — |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.